Cargando…

Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors

BACKGROUND: The vast majority of COVID-19 cases both symptomatic and asymptomatic develop immunity after COVID-19 contagion. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The aim of this study was to determine how long total anti-SARS-CoV2 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, M. Carmen, Jimenez, Ana, Ortega, Nuria, Parrado, Alba, Page, Isabel, Gonzalez, M. Isabel, Blanco-Peris, Lydia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870513/ https://www.ncbi.nlm.nih.gov/pubmed/35202394 http://dx.doi.org/10.1371/journal.pone.0264124

Ejemplares similares

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19
por: So-Osman, Cynthia, et al.
Publicado: (2022)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

Appropriate selection of convalescent plasma donors for COVID-19
por: Tedder, Richard S, et al.
Publicado: (2021)

Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
por: Pedraza, Alexandra, et al.
Publicado: (2022)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
por: Andersen, Kylie J., et al.
Publicado: (2020)

SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin
por: Volk, Andreas, et al.
Publicado: (2021)

Convalescent plasma therapy for persistent hepatitis E virus infection
por: Ankcorn, Michael, et al.
Publicado: (2019)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

CHALLENGES IN THE PRODUCTION OF COVID-19 CONVALESCENT PLASMA – ANALYSIS OF DONOR RECRUITMENT
por: Sekiya, E.J., et al.
Publicado: (2020)

Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
por: Sekiya, Eliseo Joji, et al.
Publicado: (2021)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
por: Bonetti, Tatiana Carvalho de Souza, et al.
Publicado: (2021)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

A Multiclass, Multiproduct Covid-19 Convalescent Plasma Donor Equilibrium Model
por: Nagurney, Anna, et al.
Publicado: (2021)

Case Report: Serial Cases: Prolongation of High Immunoglobulin G Level in Repetitive COVID-19 Convalescence Plasma Donor in Saiful Anwar Hospital Malang, Indonesia
por: Nurarifah, Nina, et al.
Publicado: (2021)

The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection
por: Fazeli, Alieh, et al.
Publicado: (2022)

Use of convalescent plasma in hospitalized patients with COVID-19: case series
por: Hegerova, Livia, et al.
Publicado: (2020)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
por: Dulipsingh, Latha, et al.
Publicado: (2020)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
por: Kunze, Katie L., et al.
Publicado: (2021)

Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
por: Wendel, Silvano, et al.
Publicado: (2020)

In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
por: Rojas-Jiménez, Gabriel, et al.
Publicado: (2022)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors
por: Chica-Parrado, María Rosario, et al.
Publicado: (2020)

Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report
por: Wang, Min, et al.
Publicado: (2020)

Convalescent plasma for covid19 – How long should a donor be excluded from donation?
por: Kutner, Jose M., et al.
Publicado: (2020)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
por: Wardhani, Shinta Oktya, et al.
Publicado: (2021)

P1622: ANTIPHOSPHOLIPID ANTIBODIES IN CONVALESCENT PLASMA OF DONORS RECOVERED FROM MILD COVID-19
por: Blickstein, D., et al.
Publicado: (2022)

Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors
por: Müller, Rebecca, et al.
Publicado: (2022)

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
por: Uzun, Günalp, et al.
Publicado: (2023)

Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma
por: Razumikhin, Mikhail, et al.
Publicado: (2022)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Plasma from donors convalescent from SARS-CoV-2 infection–A matter of priorities
por: Farrugia, A.
Publicado: (2020)

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
por: Klein, Sabra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f83bkjen9torpjfh0c12khfsst